Targeting EGFR mutation in non-small-cell lung cancer: challenges and future perspectives

被引:3
|
作者
Haddad, Fady G. [1 ]
Kourie, Hampig R. [1 ,2 ]
Kattan, Joseph [1 ]
机构
[1] St Joseph Univ, Fac Med, Dept Oncol, Beirut, Lebanon
[2] Bordet Inst, Fac Med, Brussels, Belgium
关键词
EGFR; non-small-cell lung cancer; T790M; CISPLATIN PLUS GEMCITABINE; 1ST-LINE TREATMENT; OPEN-LABEL; PHASE-III; CHEMOTHERAPY; GEFITINIB; AFATINIB; ERLOTINIB;
D O I
10.2217/fon-2016-0325
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:201 / 204
页数:4
相关论文
共 50 条
  • [1] Targeting EGFR in non-small-cell lung cancer
    Doroshow, JH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (02): : 200 - 202
  • [2] Nivolumab in non-small-cell lung cancer with EGFR mutation
    Yoshida, H.
    Kim, Y. H.
    Ozasa, H.
    Nagai, H.
    Sakamori, Y.
    Tsuji, T.
    Nomizo, T.
    Yasuda, Y.
    Funazo, T.
    Hirai, T.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (03) : 777 - 778
  • [3] EGFR mutation analysis in non-small-cell lung cancer
    Tapia, C.
    Savic, S.
    Bihl, M.
    Rufle, A.
    Zlobec, I.
    Terracciano, L.
    Bubendorf, L.
    [J]. PATHOLOGE, 2009, 30 (05): : 384 - 392
  • [4] Targeting the EGFR T790M mutation in non-small-cell lung cancer
    Normanno, Nicola
    Maiello, Monica Rosaria
    Chicchinelli, Nicoletta
    Iannaccone, Alessia
    Esposito, Claudia
    De Cecio, Rossella
    D'alessio, Amelia
    De Luca, Antonella
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (02) : 159 - 165
  • [5] Immunohistochemistry for EGFR Mutation Detection in Non-Small-Cell Lung Cancer
    Hitij, Nina Turnsek
    Kern, Izidor
    Sadikov, Aleksander
    Knez, Lea
    Stanic, Karmen
    Zwitter, Matjaz
    Cufer, Tanja
    [J]. CLINICAL LUNG CANCER, 2017, 18 (03) : E187 - E196
  • [6] EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
    Kobayashi, S
    Boggon, TJ
    Dayaram, T
    Janne, PA
    Kocher, O
    Meyerson, M
    Johnson, BE
    Eck, MJ
    Tenen, DG
    Halmos, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08): : 786 - 792
  • [7] Concomitant EGFR Mutation and ALK Rearrangement in Non-Small-Cell Lung Cancer
    Chen, R.
    Zhang, X.
    Wu, Y.
    Chen, H.
    Zhou, Q.
    Su, J.
    Tu, H.
    Xie, Z.
    Zhong, W.
    Yang, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2225 - S2226
  • [8] Targeting EGFR in non-small-cell lung cancer: Lessons, experiences, strategies
    Stella, Giulia M.
    Luisetti, Maurizio
    Inghilleri, Simona
    Cemmi, Francesca
    Scabini, Roberta
    Zorzetto, Michele
    Pozzi, Ernesto
    [J]. RESPIRATORY MEDICINE, 2012, 106 (02) : 173 - 183
  • [9] Metastatic non-small-cell lung cancer with EGFR mutation - case report
    Jasiowka, Marek
    Cedrych, Ida
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : G46 - G48
  • [10] EGFR mutation and non-small-cell lung cancer: EGFR test, cost and quality of life
    Thongprasert, Sumitra
    [J]. LUNG CANCER MANAGEMENT, 2012, 1 (03) : 169 - 172